Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 28, 2013
Cenduit LLC, a leading global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, NC, headquarters and its office in Basel, Switzerland. The expansion adds substantial space to the ...
read more
Tuesday, September 21, 2021
Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, and Hainan Poly Pharm Co, a generics manufacturer dedicated to providing therapeutic-value products and services to patients and customers ...
read more
Celerion is pleased to announce the expansion of clinical operations to South
Korea. Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located
within the SNUH Clinical Trials Center. This enables Celerion ...
read more
Wednesday, March 09, 2022
Celerion has announced completion of additions to its research capacity and services. This includes the opening of a new Screening and Return Center, upgraded pharmacy compounding suites, expanded Absorption, Distribution, Metabolism and Excretion (...
read more
Thursday, October 30, 2014
Celerion announces the successful recapitalization of its business through investment by [2]MTS Health Investors, LLC, the New York-based healthcare private equity firm. MTS has partnered with management and will provide capital to support future ...
read more
Friday, December 20, 2013
Celerion is proud to announce the 80th anniversary of operations at our first facility in Lincoln, Nebraska. Celerion is at the forefront of early clinical research with corporate headquarters in Lincoln, plus seven other facilities globally ...
read more
Wednesday, December 11, 2013
Celerion is pleased to announce the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Mr. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
read more
Monday, November 11, 2013
Celerion is pleased to announce the appointment of Clayton Dehn as Executive Director, Metabolic Diseases. Mr. Dehn will lead the expansion of Celerion’s current capabilities that support early Proof-of-Concept in the development of diabetes, obesity...
read more
Wednesday, April 06, 2022
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing...
read more
Monday, September 07, 2020
CATO SMS has unveiled its new brand, revealing an updated look and logo capturing the company’s offering following the merger of CATO Research, and Specialized Medical Services-oncology.
read more
Monday, September 21, 2020
CATO SMS has acquired Wilmington, NC-based Array Biostatistics to expand its offering of specialized clinical research solutions.
read more
Catalyst Clinical Research, a provider of clinical research services, announced a strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies.
read more
Catalent, Inc. (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the pricing of its initial public offering of 42,500,000 shares of...
read more
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials ...
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more